Dealmaking Quarterly Statistics, Q4 2021
A Look At M&A And Alliance Activity Across The Biopharma, Medical Device And In Vitro Diagnostics Industries, October-December 2021
Executive Summary
During Q4, biopharma merger and acquisition value reached $29.8bn and drew in $64bn in potential deal value from alliances. Device company M&A values reached $7.5bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $6.7bn.